DRUG DEVELOPMENT

CB-002 OCELOTA NOVEL HYBRID PSYCHEDELICA novel chemical entity (NCE) and non-hallucinogenic hybrid psychedelic molecule.Engineered to harness therapeutic benefits without altered perception, ideal for wider clinical adoption.